Abstract:While near infrared fluorescence (NIRF) imaging has been widely used in preclinical studies, its low tissue penetration represents a daunting problem for translational clinical imaging of neurodegenerative diseases. Retina is known as an extension of the central nerve system (CNS), and it is widely considered as a window to a brain. Therefore, retina can be considered as an alternative organ for investigating neurodegenerative diseases. From an NIRF imaging standpoint, an eye represents an ideal imaging organ, due to its minimal opacity. In this report, we demonstrated that, for the first time, Near Infrared Fluorescence Ocular Imaging (NIRFOI) could potentially be applied for diagnosis of Alzheimer's disease. In our previous studies, we described “smart” fluorescent probes for amyloid beta (Ab) (CRANAD-X (X = -2, -3, -30, -58, and -102)) and used them for non-invasive NIRF imaging of Aβ species in brains of transgenic AD mice. Here, we demonstrated that these probes also could be used for imaging of Aβs in the eyes (Fig.1). Compared to NIRF of brains, NIRFOI has remarkable translational potential for future human studies, as the eye has significantly better transparency for optical imaging. Moreover, our preliminary results demonstrated that NIRFOI could provide much higher sensitivity for imaging Abs than brain NIRF did (Fig.1). This large margin is very important for both diagnosis and therapy response monitoring. Although fluorescence microscopic imaging has been used for detection of Ab plaques in AD mice and human AD patients, but it could not be used to detect soluble Aβs, because there is no observable morphology of soluble Aβs under fluorescence microscope. However, NIRFOI captures signals with a wide angle (large FOV), and can collect all of the signals from eyes. Therefore we believe that NIRFOI imaging is one of such technologies that can capture the imaging signals from both soluble and insoluble Aβ species.

NEAR INFRARED FLUORESCENCE IMAGING OF REACTIVE OXYGEN SPECIES IN ALZHEIMER’S DISEASE VIA TRANSFORMATION FROM “VISIBLE” TO “INVISIBLE”

Oxalate-curcumin-based probe for micro- and macroimaging of reactive oxygen species in Alzheimer's disease

NEAR INFRARED FLUORESCENCE OCULAR IMAGING (NIRFOI) OF AMYLOID BETA SPECIES IN ALZHEIMER’S DISEASE

An activatable near-infrared fluorescent probe with large Stokes shift for visualizing peroxynitrite in Alzheimer's disease models

An Activatable Near-Infrared Fluorescent Probe with Large Stokes Shift for Visualizing Peroxynitrite in Alzheimer’s Disease Models

Imaging Hydrogen Peroxide in Alzheimer'S Disease Via Cascade Signal Amplification

Near-infrared Fluorescence Molecular Imaging of Amyloid Beta Species and Monitoring Therapy in Animal Models of Alzheimer’s Disease

An Activity-Based Fluorescent Probe for Imaging Fluctuations of Peroxynitrite (ONOO-) in the Alzheimer's Disease Brain.

Redox Oxygen Species‐Responsive Nanotheranostics with Dual‐Channel Fluorescent Turn‐On for Early Diagnosis and Targeted Therapy of Alzheimer's Disease

Development of Near-Infrared Fluorescent Probes for Use in Alzheimers Disease Diagnosis

Development of Near-Infrared Fluorescent Probes for Use in Alzheimer’s Disease Diagnosis

Near Infra-Red Light Treatment of Alzheimer's Disease

Near-infrared Fluorescence Ocular Imaging (NIRFOI) of Alzheimer's Disease.

Near infra-red light treatment of Alzheimer’s disease

Two-photon fluorescence imaging of the cerebral peroxynitrite stress in Alzheimer's disease

An Activity-Based Sensing Fluorescent Probe for Monitoring Endogenous Peroxynitrite in Alzheimer's Disease Models

Early Detection of Alzheimer’s Disease Using Non-invasive Near-Infrared Spectroscopy

Design of an Activatable NIR-II Nanoprobe for the in Vivo Elucidation of Alzheimer's Disease-Related Variations in Methylglyoxal Concentrations.

In Situ Imaging of Formaldehyde in Live Mice with High Spatiotemporal Resolution Reveals Aldehyde Dehydrogenase-2 As a Potential Target for Alzheimer's Disease Treatment.

In Vivo Target Bio-Imaging of Alzheimer's Disease by Fluorescent Zinc Oxide Nanoclusters.

Diagnosis of Alzheimer's Disease and in Situ Biological Imaging Via an Activatable Near-Infrared Fluorescence Probe.